Can the benefits of lung cancer screening be extended to never-smokers?
Recent data provide further evidence that non-risk-based screening can improve survival if biomarkers can be identified to target screening to those at the highest risk
Is there a role for GLP-1 in the prevention and treatment of cancer?
Interest is growing rapidly in the field of oncology in the anti-obesity drug target that has recently been investigated in large retrospective studies and preclinical models
ctDNA and RNA-based tests are expanding colorectal cancer screening options
The availability of simpler, less-invasive methodologies may help to encourage participation in secondary prevention programmes
Cancer Control Principles
Microplastics and cancer: a microscopic threat, a macro challenge
Evidence is growing for a potential role of microplastics in cancer development, but more solid research is needed
Will AI reshape breast cancer screening?
While AI tools have shown promise in reducing false positives and aiding radiologists, large prospective trials are now exploring how technology should be integrated in screening programmes
Preventing the rise in obesity-related cancers in Asia
Long-term multisectoral preventive actions that take into account local requirements are needed
From precision oncology to molecular prevention – a new role for our profession?
As rapid scientific and technological progress raises hopes of more cancers being intercepted at the earliest stages in the future, ESMO delves deeper into prevention to ensure education and guidance for medical oncologists in this moving field
Cancer Control Principles
How to mark a tangible impact in cancer control
Recent research shows that tailored strategies and political commitment can revert current epidemiology trends of cancer
Cancer Prevention
The sunscreen dilemma – how to make skin cancer prevention environmentally friendly?
The use of sunscreens is essential to protect the skin from UV exposure, but they may enter waterways damaging the ecosystem
Why are gastrointestinal cancer patients getting younger?
Research is moving forward to adapt clinical practice to a new wave of early-onset cases of cancer in the digestive tract